Company Overview
| Stock Name | 复锐医疗科技 |
|---|---|
| Stock Code | 01696 |
| Company Full Name | 复锐医疗科技 |
| Industry | 醫療保健 |
| Principal Activities | 主要從事設計、開發、制造及銷售醫療美容器械。 |
| Listing Date | 2017-09-19 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 3079895 以色列凱撒利亞工業園區哈哈拉什街18號Ofek 15號樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.sisram-medical.com |
| Share Registrar | |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 8.88 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 5.8% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 293,040,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 8.12 |
|---|---|
| First Day Open | HK$ 8.79 |
| First Day Change | -8.56% |
| First Day Volume | 38948500.0 |
| First Day Turnover | 329538000.0 |
Use of Proceeds
| Use of Proceeds | 1、約18.6%，或約128.4百萬港元，預期用于擴展我們的銷售渠道及分銷網絡以及加強我們的營銷力度； 2、約18.6%，或約128.4百萬港元，用于資本開支； 3、約14.0%，或約96.3百萬港元，預期用于研究及開發活動； 4、約9.3%，或約64.2百萬港元，預期將用于償還關聯方復星實業（香港）有限公司的收購貸款； 5、約29.5%，或約202.5百萬港元，預期將用于策略性收購、設立戰略合作關系，以及其他業務發展； 6、約10.0%，或約68.9百萬港元，預期用作營運資金及一般公司用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
中国国际金融香港证券有限公司 CE AEN894
富瑞金融集团香港有限公司 CE ATS546
Overall Coordinators (3)
中国国际金融香港证券有限公司 CE AEN894
富瑞金融集团香港有限公司 CE ATS546
复星国际证券有限公司 CE AAF432
Joint Bookrunners (5)
中国国际金融香港证券有限公司 CE AEN894
富瑞金融集团香港有限公司 CE ATS546
复星国际证券有限公司 CE AAF432
海通国际证券有限公司 CE AAF806
华泰金融控股（香港）有限公司 CE AOK809
Joint Lead Managers (5)
中国国际金融香港证券有限公司 CE AEN894
富瑞金融集团香港有限公司 CE ATS546
复星国际证券有限公司 CE AAF432
海通国际证券有限公司 CE AAF806
华泰金融控股（香港）有限公司 CE AOK809
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 纽顿医学美容集团有限公司 | 29,637,888 HKD | — | 0.76% | — | 6 months | 2018-03-19 |
| 2 | 上海自贸试验区一期股权投资基金合伙企业(有限合伙) | 116,999,328 HKD | — | 2.99% | — | 6 months | 2018-03-19 |
| 3 | 升泰有限公司 | 77,998,368 HKD | — | 2.00% | — | 6 months | 2018-03-19 |
Directors & Management
| Chairman | Lior Moshe DAYAN |
|---|---|
| Company Secretary | 方前厲 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 上海復星醫藥(集團)股份有限公司(71.16%) |
|---|
